Table 3. Co-infection with hepatitis and demographic data on patients stratified according to their hepatitis status.
A | Hepatitis | Number | Percent (of total) | ||||
HCV | 148 | 46.8 | |||||
HBV | 11 | 3.5 | |||||
HCV+HBV | 17 | 5.4 | |||||
Negative | 130 | 41.1 | |||||
Not Knowna | 12 | 3.8 | |||||
Total | 318 | 100 | |||||
B | Hepatitis | Negative (n = 130) | Positive a (n = 176) | p | |||
Number (% of TG) | Percent (of total) | Number (% of TG) | Percent (of total) | ||||
Transmission Groups (percentage in the group) | Hetero | 49(74%) | 37.7 | 17(26%) | 9.7 | <0.0001 | |
IVDU | 49(25%) | 37.7 | 141(71%) | 80.0 | <0.0001 | ||
MSM | 30(64%) | 23.1 | 15(32%) | 8.5 | 0.001 | ||
Other | 2(29%) | 1.5 | 3(43%) | 1.7 | 1 | ||
Total | 130 | 100 | 176 | 100 | |||
Birth Place (percentagein the group) | Is | 42(78%) | 32.0 | 10(19%) | 5.7 | <0.0001 | |
FSU | 77(32%) | 59.2 | 159(65%) | 90.3 | <0.0001 | ||
Otherb | 14(55%) | 10.8 | 7(35%) | 4.0 | 0.1 | ||
Total | 130 | 100 | 176 | 100 |
176 of the 318 A/AE-HIV carriers (55.3%) were co-infected with hepatitis: 148 had HCV, 11 HBV and 17 had both. 130 were not infected with hepatitis and for 12 there was no information.
For 8 IVDU, 2 MSM and 2 Others the status of hepatitis infection was unknown.
Other birth sites were in Africa, America, Asia, Europe, or unknown.
IVDU – Intravenous drug users; MSM – men who have sex with men; TG – Transmission group.